NCT05981989 Epidural Electrical Stimulation for Stroke Patients - Improve Motor and Sensory Function and Alleviate Pain
| NCT ID | NCT05981989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Buddhist Tzu Chi General Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-04-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to verify whether epidural electrical stimulation (EES) of the cervical spinal cord can activate muscles of the upper limbs in people with hemiplegia following a stroke.
Eligibility Criteria
Inclusion Criteria: * Between 20 and 70 years of age * First-ever clinical manifest stroke * Right or left hemiparesis * Scores higher than 7 and lower than 45 on the Fugl-Meyer scale. * Expected will undergo spinal cord stimulation surgery. * Able to comply with procedures and follow up. * Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in upper extremity rehabilitation or testing activities. Exclusion Criteria: * Pregnancy or breast feeding. * Have Major depressive disorder. * Had a mental illness within one year or been treated in the past. * Have significant cognitive impairment (MMSE\<24) or serious disease that could affect the ability to participate in study activities. * Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention. * Receiving anticoagulant, anti-spasticity or anti-epileptic medications prior to or throughout the duration of the study. * Unable to read and/or comprehend the consent form. * Have concerns about this trial and do not sign consent. * Presence of joint contractures deemed by study clinician/investigator to be too severe to participate in study activities.
Contact & Investigator
Sheng-Tzung Tsai, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Hualien Tzu Chi General Hospital
Frequently Asked Questions
Who can join the NCT05981989 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05981989 currently recruiting?
Yes, NCT05981989 is actively recruiting participants. Contact the research team at flydream.tsai@gmail.com for enrollment information.
Where is the NCT05981989 trial being conducted?
This trial is being conducted at Hualien City, Taiwan.
Who is sponsoring the NCT05981989 clinical trial?
NCT05981989 is sponsored by Buddhist Tzu Chi General Hospital. The principal investigator is Sheng-Tzung Tsai, M.D., Ph.D. at Hualien Tzu Chi General Hospital. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.